James Joyce, MPH

James Joyce is a Delivery Director within the Biopharma group of Global Project Delivery, specializing in Phase Ib through Phase III studies in Obesity as well as Liver Disease including MASH/MASLD (metabolic dysfunction-associated steatohepatitis and metabolic dysfunction-associated steatotic liver disease), Primary Sclerosing Cholangitis and Primary Biliary Cholangitis and Cirrhosis indications. James brings extensive core lab imaging experience, biopsy histology and pathology management, sponsor portfolio oversight and governance. He has worked for 25 years in the pharmaceutical industry, 15 years of which have been at Fortrea (formerly Labcorp and Covance) in Project Management and Director roles. He is based in Atlanta, Georgia, USA.